Status:
COMPLETED
Indo-cyanine Green (ICG) in Paediatric Oncology MIS
Lead Sponsor:
Birmingham Women's and Children's NHS Foundation Trust
Conditions:
Pediatric Renal Tumor
Metastatic Osteosarcoma
Eligibility:
All Genders
1-15 years
Phase:
PHASE4
Brief Summary
Indo-cyanine green (ICG) is a dye that has been used for a variety of adult and paediatric uses since 1956. Over the past few years, near infrared (NIRF) technology has been developed which allow is u...
Detailed Description
The purpose of this study is to show the feasibility of using ICG in combination with NIRF and MIS in paediatric oncology surgery. It has been used increasingly over the past few years for a range of ...
Eligibility Criteria
Inclusion
- Age between 1 day and 15 years 365 days
- Have a diagnosis of an intra-abdominal, retroperitoneal or intra-thoracic tumour or pulmonary metastases
- Require surgery as part of their treatment
- Tumour or metastasis suitable for MIS resection based on assessment of the pre-operative imaging
Exclusion
- Allergic to ICG
- Allergic to iodine or iodides
- Due to receive radioactive iodine as part of a treatment
- Hyperthyroidism
- Unwilling to participate
- Chronic Kidney Disease stage V
Key Trial Info
Start Date :
April 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04854018
Start Date
April 30 2021
End Date
September 30 2022
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham children's hospital
Birmingham, United Kingdom, B4 6NH